Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | ACE | P12821 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | APAF1 | O14727 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.60 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.60 |
| ▸ | ITGAL | P20701 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | ECE1 | P42892 | 3/20 | 0.57 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7558085 | 1.00 | ALOX15 (0.67) | ALOX15ACESMN1; SMN2POLBKDM4E | |
| SCHEMBL231803 | 0.87 | ALOX15 (0.66) | ALOX15ACESMN1; SMN2POLBKDM4E | |
| SCHEMBL231804 | 0.87 | ALOX15 (0.66) | ALOX15ACESMN1; SMN2POLBKDM4E | |
| SCHEMBL5379545 | 0.86 | ALOX15 (0.59) | ALOX15ACESMN1; SMN2ITGB2ICAM1 | |
| SCHEMBL5379543 | 0.86 | ALOX15 (0.59) | ALOX15ACESMN1; SMN2ITGB2ICAM1 | |
| SCHEMBL29063383 | 0.85 | ALOX15 (0.63) | ALOX15ACESMN1; SMN2POLBKDM4E | |
| SCHEMBL28200409 | 0.85 | ALOX15 (0.63) | ALOX15ACESMN1; SMN2POLBKDM4E | |
| SCHEMBL27851269 | 0.85 | ALOX15 (0.63) | ALOX15ACESMN1; SMN2POLBKDM4E | |
| SCHEMBL31210300 | 0.85 | ALOX15 (0.67) | ALOX15ACESMN1; SMN2POLBKDM4E | |
| SCHEMBL28926747 | 0.84 | ALOX15 (0.57) | ALOX15ACESMN1; SMN2POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4110955-A1 | METHODS FOR DIAGNOSING, PROGNOSING AND MANAGING TREATMENT OF BREAST CANCER | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-01-04 | — | — | EP | disclosed |
| EP-4076508-A1 | METHODS AND VACCINE COMPOSITIONS TO TREAT CANCERS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2022-10-26 | — | — | EP | disclosed |
| EP-4045686-A1 | METHODS FOR DIAGNOSING NASAL INTESTINAL TYPE ADENOCARCINOMAS | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2022-08-24 | — | — | EP | disclosed |
| EP-3938051-A1 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | Aileron Therapeutics, Inc. (US) | 2022-01-19 | — | — | EP | disclosed |
| EP-3918332-A1 | METHODS AND COMPOSITIONS FOR IDENTIFYING WHETHER A SUBJECT SUFFERING FROM A CANCER WILL ACHIEVE A RESPONSE WITH AN IMMUNE-CHECKPOINT INHIBITOR | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-12-08 | — | — | EP | disclosed |
| EP-3898699-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCERS BY IMMUNO-MODULATION USING ANTIBODIES AGAINST CATHESPIN-D | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-10-27 | — | — | EP | disclosed |
| WO-2021144426-A1 | METHODS AND COMPOSITIONS FOR TREATING MELANOMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-07-22 | — | — | WO | disclosed |
| WO-2021123243-A1 | METHODS AND VACCINE COMPOSITIONS TO TREAT CANCERS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021083959-A1 | METHODS AND COMPOSITIONS FOR TREATING UVEAL MELANOMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-05-06 | — | — | WO | disclosed |
| WO-2021074391-A1 | METHODS FOR DIAGNOSING NASAL INTESTINAL TYPE ADENOCARCINOMAS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-04-22 | — | — | WO | disclosed |
| WO-2021064180-A1 | METHODS AND COMPOSITIONS FOR MODULATING MACROPHAGES POLARIZATION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-04-08 | — | — | WO | disclosed |
| WO-2021067313-A1 | EUKARYOTIC SEMI-SYNTHETIC ORGANISMS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-04-08 | — | — | WO | disclosed |
| WO-2021048292-A1 | METHODS AND COMPOSITIONS FOR TREATING MELANOMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2021-03-18 | — | — | WO | disclosed |
| WO-2020221796-A1 | METHODS AND COMPOSITIONS FOR TREATING MELANOMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2020-11-05 | — | — | WO | disclosed |
| WO-2020190742-A1 | PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF | AILERON THERAPEUTICS, INC. (US) | 2020-09-24 | — | — | WO | disclosed |
| WO-2020157131-A1 | METHODS AND COMPOSITIONS FOR IDENTIFYING WHETHER A SUBJECT SUFFERING FROM A CANCER WILL ACHIEVE A RESPONSE WITH AN IMMUNE-CHECKPOINT INHIBITOR | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2020-08-06 | — | — | WO | disclosed |
| WO-2020127411-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCERS BY IMMUNO-MODULATION USING ANTIBODIES AGAINST CATHESPIN-D | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020120592-A1 | METHODS AND COMPOSITIONS FOR PREDICTING AND TREATING MELANOMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2020-06-18 | — | — | WO | disclosed |
| WO-2020115261-A1 | METHODS AND COMPOSITIONS FOR TREATING MELANOMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2020-06-11 | — | — | WO | disclosed |
| WO-2002069927-A1 | COMPOSITIONS COMPRISING MELATONIN AND VITAMIN A | ASAT AG APPLIED SCIENCE & TECHNOLOGY (CH) | 2002-09-12 | — | — | WO | disclosed |